Targeted Blood Plasma Proteomics and Hemostasis Assessment of Post COVID-19 Patients with Acute Myocardial Infarction
International Journal of Molecular Sciences · 2023
DOI: 10.3390/ijms24076523 ↗Kurz gefasst
Fachartikel in der Zeitschrift International Journal of Molecular Sciences, 2023. Verfasst von Anna Kalinskaya und 12 weiteren Autor:innen. Beteiligte Einrichtung: Laboratory of Atherothrombosis, Cardiology Department, A.I. Evdokimov Moscow State University of Medicine and Dentistry, 127473 Moscow, Russia. Hauptthemen laut MEDLINE: COVID-19, Myocardial Infarction. Die Arbeit wurde bisher 6-mal zitiert (Crossref) und nennt 47 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Moscow Government.
Abstract (Originalsprache)
The molecular mechanisms underlying cardiovascular complications after the SARS-CoV-2 infection remain unknown. The goal of our study was to analyze the features of blood coagulation, platelet aggregation, and plasma proteomics in COVID-19 convalescents with AMI. The study included 66 AMI patients and 58 healthy volunteers. The groups were divided according to the anti-N IgG levels (AMI post-COVID (n = 44), AMI control (n = 22), control post-COVID (n = 31), and control (n = 27)). All participants underwent rotational thromboelastometry, thrombodynamics, impedance aggregometry, and blood plasma proteomics analysis. Both AMI groups of patients demonstrated higher values of clot growth rates, thrombus size and density, as well as the elevated levels of components of the complement system, proteins modifying the state of endothelium, acute-phase and procoagulant proteins. In comparison with AMI control, AMI post-COVID patients demonstrated decreased levels of proteins connected to inflammation and hemostasis (lipopolysaccharide-binding protein, C4b-binding protein alpha-chain, plasma protease C1 inhibitor, fibrinogen beta-chain, vitamin K-dependent protein S), and altered correlations between inflammation and fibrinolysis. A new finding is that AMI post-COVID patients opposite the AMI control group, are characterized by a less noticeable growth of acute-phase proteins and hemostatic markers that could be explained by prolonged immune system alteration after COVID-19.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Laboratory of Atherothrombosis, Cardiology Department, A.I. Evdokimov Moscow State University of Medicine and Dentistry, 127473 Moscow, Russia.
- I.V. Davydovsky Moscow City Clinical Hospital, Moscow Department of Healthcare, 117463 Moscow, Russia.
- Emanuel Institute for Biochemical Physics, Russian Academy of Science, 119991 Moscow, Russia.
- Center for Molecular and Cellular Biology, Skolkovo Institute of Science and Technology, 121205 Moscow, Russia.
ORCID-Profile: Anna Kalinskaya, George Rusakovich, Anna Bugrova, Evgeny Nikolaev, Elena Vasilieva
Förderung
- Moscow Government
Zitieren
APA
Kalinskaya, A., Vorobyeva, D., Rusakovich, G., Maryukhnich, E., Anisimova, A., Dukhin, O., Elizarova, A., Ivanova, O., Bugrova, A., Brzhozovskiy, A., Kononikhin, A., Nikolaev, E., & Vasilieva, E. (2023). Targeted Blood Plasma Proteomics and Hemostasis Assessment of Post COVID-19 Patients with Acute Myocardial Infarction. International Journal of Molecular Sciences. https://doi.org/10.3390/ijms24076523
Vancouver
Kalinskaya A, Vorobyeva D, Rusakovich G, Maryukhnich E, Anisimova A, Dukhin O, et al. Targeted Blood Plasma Proteomics and Hemostasis Assessment of Post COVID-19 Patients with Acute Myocardial Infarction. International Journal of Molecular Sciences. 2023. doi:10.3390/ijms24076523
BibTeX
@article{Kalinskaya2023,
author = {Kalinskaya, Anna and Vorobyeva, Daria and Rusakovich, George and Maryukhnich, Elena and Anisimova, Alexandra and Dukhin, Oleg and Elizarova, Antonina and Ivanova, Oxana and Bugrova, Anna and Brzhozovskiy, Alexander and Kononikhin, Alexey and Nikolaev, Evgeny and Vasilieva, Elena},
title = {Targeted Blood Plasma Proteomics and Hemostasis Assessment of Post COVID-19 Patients with Acute Myocardial Infarction},
journal = {International Journal of Molecular Sciences},
year = {2023},
doi = {10.3390/ijms24076523}
}
EUVIMED